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Euphorbiaceae (Croton macrostachyus H.; 巴豆 ba dou) is used in Ethiopian folklore medicine for the
treatment of malaria, gonorrhea, diabetes, wounds, fungal infections, and helminths. No scientiﬁc in-
vestigations have been performed to substantiate these claims. This study aimed to investigate the in vivo
antiplasmodial activity of 80% methanol extract of the fruit and the root of Croton macrostachyus H. in a
rodent model of malaria. The rodent malaria parasite Plasmodium berghei was used to inoculate healthy
8-week-old male Swiss albino mice weighing 23e27 g. Each of the hydroalcoholic crude extracts
(200 mg/kg, 400 mg/kg, and 600 mg/kg) were administered to different groups of mice. The parameters
of parasitemia, survival time, body weight, temperature, and packed cell volume were determined using
Peter's test and Rane's test. Both extracts signiﬁcantly inhibited parasitemia and increased survival time
in infected mice. Maximum suppression and prolongation were obtained at the highest doses used in the
study. The crude extracts prevented loss of weight and temperature, but did not affect the packed cell
volume. This study suggests that the root and fruit extracts of the plant both have promising anti-
plasmodial activity against Plasmodium berghei in a dose-dependent manner, which supports the folk-
loric use of the plant for treating malaria.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Malaria is generally a major public health problem throughout
the world, particularly in developing countries. It causes an esti-
mated 0.7e1 million deaths per year.1,2 Approximately one-half of
the world's population is at risk of contracting malaria.1,2 Most
cases (78%) occur in the African region, followed by Southeast Asia
(15%) and Eastern Mediterranean regions (5%).3 Malaria is pre-
ventable and curable; however, it remains one of the greatest global
public health problems, especially in sub-Saharan Africa.4
Because of increasing resistance to available antimalarial agents,
there is broad consensus on the need to develop new antimalarial
drugs. Antimalarial drug development can follow several strategies,
which range from minor modiﬁcations of existing agents to the
design of novel agents that act against new targets.5for Food and Biomolecules,
molecules, National Taiwan UniveNatural products have been important sources of different drugs
currently available to treat severe Plasmodium falciparum malaria.
Quinine and derivatives of artemisinin are the two most important
products of plants useful in clinical practice. In the case of artemi-
sinin, relatively simple chemical modiﬁcations of the natural parent
compound have led to a series of highly potent antimalarials.6,7 The
development of these two important drugs from natural sources and
the utilization of many plants traditionally in various parts of the
world trigger the conduction of in vitro and in vivo studies because
natural products can be a source of new antimalarial drugs.
Crotonmacrostachyus H. (巴豆 ba dou) is a deciduous tree that is
3e25 m high with large green leaves. It is commonly found on
forest edges along rivers, around lakes, woodlands, wooded
grasslands, and along road sides. It is native to Eritrea, Ethiopia,
Kenya, Nigeria, Tanzania, and Uganda.8,9 The Shinasha, Agew-awi,
and Amhara people of Ethiopia use it to treat malaria.10
Up to 80% of the Ethiopian population uses traditional medicine
because of the cultural acceptability of healers, the relatively low
cost of traditional medicine, and difﬁcult access to modern health
facilities.11 Works that have evaluated the safety and efﬁcacy ofrsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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is rich in ﬂora that could be sources of different, new antimalarial
agents. Therefore, further screening of plants cannot be over-
emphasized. This study therefore aimed to enrich the screened
Ethiopianmedicinal plants and to evaluate the claimed antimalarial
activity of Euphorbiaceae (Croton macrostachyusH.;巴豆 ba dou) by
traditional medicine practitioners.
2. Materials and methods
2.1. Plant materials
The fresh fruit and root of the plant were collected in April 2013
from the Shindi district of Amhara regional state, which is 420 km
southwest of Bahir Dar, Ethiopia. The fresh fruits and root were
wrapped in plastic sheets during transportation. A taxonomist from
Addis Ababa University (Addis Ababa, Ethiopia) identiﬁed the plant
as Croton macrostachyus. A specimen of the plant was deposited
(voucher no. LB001) at the National Herbarium in the College of
Natural Sciences at Addis Ababa University for future reference.
2.2. Animals and the parasite
Male Swiss albino mice (age, 8 weeks; weight, 23e27 g) were
used; they were bred and maintained at the Ethiopian Health
Nutrition and Research Institute (Addis Ababa, Ethiopia). They were
housed in the animal house of the Amhara Regional State Animal
Health Institute (Bahir Dar, Ethiopia) at a temperature of 22 ± 3 C,
relative humidity of 40e50% and 12-hour light/12-hour dark cycle.
The animals were acclimatized for 2 weeks to the experimental
environment and provided with commercial food and water ad
libitum. A chloroquine-sensitive strain of Plasmodium berghei
(ANKA) was obtained from the School of Pharmacy in the Depart-
ment of Pharmacology at Gondar University (Gondar, Ethiopia). The
parasites were maintained by serial passage of blood from infected
mice to uninfected mice on a weekly basis.
2.3. Extraction
The plant materials (i.e., fruit and root) were air dried at room
temperature under shade and reduced to appropriate size by
grinding with an electric mill. A total of 500 g of the dried root and
fruit were each extracted by maceration (100 g of dried fruit and
root in 500 mL of 80% methanol) for 72 hours. The extraction
process was facilitated by an orbital shaker at 120 rpm. The mixture
was ﬁrst ﬁltered using gauze and further ﬁltered byWhatman ﬁlter
paper No. 1 (Whatman, Beaconsﬁeld, England). The residue was re-
macerated for another 72 hours twice. The ﬁltered extract was then
dried by a rotary evaporator (Buchi Rota Vapor, Switzerland) at a
temperature of 40 C. After drying, 54 g (10.8%) and 50 g (10%) of
the dry extract of the fruit and root, respectively, were harvested.
The dried extracts were maintained at e20 C until use.
2.4. Acute toxicity testing
Six female Swiss albino mice were randomly divided into two
groups of threemice per cage. After being fasted for 2 hours,13,14 the
mice in the ﬁrst group were orally administered 2 g/kg of the fruit
extract dissolved in 2% Tween 80, and observed for any signs of
toxicity. The mice in the second group were administered 2 g/kg of
the root extract dissolved in distilled water; they were observed for
gross changes such as loss of appetite, hair erection, lacrimation,
tremors, convulsions, salivation, diarrhea, mortality, and other
signs of overt toxicity.132.5. Phytochemical screening
Following standard procedures, preliminary screening tests
were performed on the crude extracts to detect different secondary
metabolites.15e19
2.6. In vivo antimalarial tests
2.6.1. Parasite inoculation
The donors were four albino mice that were previously infected
with P. berghei and had parasitemia levels of 20%, 24%, 25%, and 25%.
The parasitemia of the donor mice was ﬁrst determined. The donor
mice were then sacriﬁced by decapitation and their blood was
collected into a Petri dish treated with 0.5% trisodium citrate. The
blood was then diluted with physiological saline (0.9%). The dilu-
tion was based on the parasitemia of the donor mice and the red
blood cell count of the normal mice20 so that 1 mL blood contained
5  107 infected erythrocytes. Each mouse was administered
intraperitoneally with 0.2 mL of this diluted blood, which con-
tained 1  107 P. berghei-infected erythrocytes.
2.6.2. Grouping and dosing of animals
Fifty mice for each of the extracts were infected and were
randomly divided into 20 groups of ﬁvemice per group. Themice in
groups 1e10 (G1e10) were used to evaluate the antimalarial effects
of the fruit using Peter's test and Rane's test. Three fruit extract
doses were used: 200 mg/kg (F200), 400 mg/kg (F400), and
600 mg/kg (F600). The negative and positive controls were orally
administered 2% Tween 80 (1 mL/100 g of mouse body weight) and
chloroquine 15 mg/kg (CQ15), respectively. The mice in groups
11e20 (G11e20) were used for the root extract. Three root extract
doses were used: 200 mg/kg (R200), 400 mg/kg (R400), and
600 mg/kg (R600). The negative and positive controls were orally
administered distilled water (DW) (2 mL/100 g of mouse body
weight) and CQ15, respectively.13 The doses were selected based on
the results of the acute toxicity study. A standard gavage was used
for the oral administration of the extracts, the vehicles, and the
standard drug. The duration of the administration depended on the
type of test.
2.6.3. The 4-day suppressive test
This test was used to evaluate the schizontocidal activity of the
extracts against P. berghei infection in mice. The method used was
described by Peter et al.21 The infectedmicewere randomly divided
into their respective groups, as described under the “Grouping and
dosing of animals” section (Amhara State Animal Health Institute).
Treatment was started 3 hours after the mice had been inoculated
with the parasite on Day 0. Treatment was then continued daily for
4 days from Day 0 to Day 3. After giving the treatment for 4 days, a
thin blood ﬁlm was obtained on Day 4 to determine parasitemia
and percentage inhibition. In addition, each mouse was attended
daily for the determination of survival time after treatment. Rectal
temperature, packed cell volume (PCV), and body weight were also
recorded.
2.6.4. Rane's test
The curative potential of the crude extract and the most active
fraction were evaluated using the method described by Ryley and
Peters.22 On Day 0, the standard inocula of 1 $ 107 infected eryth-
rocytes was inoculated in mice intraperitoneally. Seventy-two
hours later, the mice were randomly divided into their respective
groups and dosed accordingly once daily for 4 days. A Geimsa-
stained thin blood ﬁlm was prepared from the tail blood of each
mouse daily for 5 days to monitor the parasitemia level. The sur-
vival time for each group was determined by ﬁnding the average
Table 1
Phytochemical constituents of the root and fruit extracts of Croton macrostachys.
Secondary metabolites Fruit extract Root extract
Alkaloids þ þ
Saponins þ þ
Phenolic compounds þ þ
Cardiac glycosides e e
Tannins þ þ
Flavonoids þ þ
Terpenoids þ þ
Anthraquinones e e
Phlobatannins e þ
, absent; þ, present.
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group for 30 days (D0eD29). Rectal temperature, PCV, and body
weight were also recorded.
2.6.5. PCV measurement
The PCV was measured to predict the effectiveness of the test
extract and fractions in preventing hemolysis resulting from
increased parasitemia associated with malaria. Heparinized capil-
lary tubes were used to collect blood from the tail of themouse. The
capillary tubes were ﬁlled with blood to three-quarters of their
height and sealed at the dry end with sealing clay. The tubes were
then placed in a microhematocrit centrifuge (Gelmanin-Hawksley,
Lancing, England) with the sealed end outwards, and centrifuged
for 5minutes at 11,000 rpm. The tubes were then removed from the
centrifuge and the PCV was determined using the standard Micro-
Hematocrit Reader (Hawksley and Sons). The PCV is a measure of
the proportion of red blood cells (RBC) to plasma and is measured
before inoculating the parasite and after treatment by the following
relationship:
PCV ¼ volume of erythrocytes in a given volume of blood/total
blood volume
2.6.6. Parasitemia measurement
Thin smears of blood were produced from the blood obtained
fromthe tail of eachmouseonDay4andDays3e7 forPeter's test and
Rane's test, respectively. The smears were applied on microscope
slides (76 mm $ 26 mm; Menzel-Glaser, Braunschweig, Germany),
ﬁxed with absolute methanol for 15 minutes, and stained with 10%
Geimsa stain at pH 7.2 for 15 minutes. The stained slides were then
washed gently using DW and then air dried at room temperature.
Two stained slides for each mouse were examined under an
Olympus microscope (CHK2-F-GS, Taiwan) with an oil immersion
nose piece at 100 magniﬁcation power. Three different ﬁelds on
each slide were examined to count the infected RBC. The average of
the results was used to calculate the average parasitemia level. The
percent parasitemia was calculated using the following formula23:
% Parasitemia ¼ Number of parasitized RBC
Total number of RBC
 100
The percent parasitemia suppression of the extracts was
compared with respect to the controls. Parasitemia suppression
was calculated using the following formula24:% Suppression ¼ Mean parasitemia of negative controlmean parasitemia of treated group
Mean parasitemia of negative control
 1002.6.7. Monitoring of body weight and temperature changes
The body weight of each mouse in all groups was measured
using a sensitive digital weighing balance (Mettler Toledo, Grei-
fensee, Switzerland) before infection and after the completion of
the treatment for Peter's test and Rane's test. The rectal tempera-
ture of the mice in all groups was measured by a digital rectal
thermometer before infection and after the completion of the
treatment for both tests.
2.7. Ethical consideration
Theanimalsweremaintainedandcared for inaccordancewith the
international guidelines for theuse andmaintenanceof experimentalanimals.13 The study protocol was approved by the board of ethics of
the College of Medicine and Health sciences of Bahir Dar University
(Bahir Dar, Ethiopia). A formal letter was written to the concerned
bodies of the College of Medicine and Health Sciences postgraduate
and research coordinator. Diethyl ether was used for euthanasia.
2.8. Data analysis
Data are expressed as the mean ± the standard error of the
mean. The data were analyzed using Windows SPSS Version 16.0.
One-way analysis of variance (ANOVA) followed by Tukey's honest
signiﬁcant difference post-hoc test was used to determine statistical
signiﬁcance in the comparisons of parasitemia suppression, weight,
PCV, rectal temperature, and survival time among groups. Values of
p < 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Phytochemical screening
Phytochemical screening of the hydroalcoholic crude extracts of
the fruit and root of Croton macrostachyus revealed the presence of
alkaloids, phenolic compounds, tannins, terpenoids, saponins, and
ﬂavonoids. Anthraquinones and cardiac glycosides were absent in
both extracts. Phlobatannins were present only in the root extract
(Table 1).
3.2. Toxicity studies
The acute toxicity study indicated that both extracts caused no
mortality at the dose used (2 g/kg) within the ﬁrst 24 hours and forthe next 14 days. Physical and behavioral observations of the
experimental mice also revealed no visible signs of acute toxicity
such as lacrimation, loss of appetite, tremors, hair erection, sali-
vation, and diarrhea.
3.3. Effect of the 4-day suppressive test
The results of the study showed that the fruit extract displayed a
very good chemosuppressive activity against P. Berghei (Table 2).
Percentage inhibition analysis indicated that the extracts produced
a dose-dependent decrease in all animals on the 5th day of para-
sitemia (p < 0.001), compared to the negative controls. The fruit
extract F600 and root extract R600 exhibited a signiﬁcant parasite
Table 2
Parasitemia and survival timemeasurements in the 4 day suppressive test of the root
and fruit extracts of Croton macrostachys.
Extract
administered
Animal
group
Parasitemia
level
% Suppression Survival date
Fruit extract CON 30 ± 0.97 0 6 ± 0.36
F200 18 ± 1.73 40a3,b3,c3 9 ± 0.33a1,b3,c3
F400 9 ± 0. 31 70a3,b1,c3 13 ± 0.42a3,b3,c3
F600 4 ± 0.40 87a3 16 ± 0.60a3,c3
CQ15 0.0 100a3 30±0a3
Root extract CON 32 ± 1.62 0 7 ± 0.17
R200 17 ± 0.54 44a3,c3,d3 10 ± 1.14a1,c3,d3
R400 13 ± 0.71 75a3,c3,d1 14 ± 0.56a3,c,3,d3,
R600 3.5 ± 0.52 89a3 19 ± 1.15a3,c3
CQ15 0.0 100a3 30.00 ± 0.00a3
Data are expressed asmeans ± SEM; n¼ 5; a¼ compared to control, b¼ to F600mg/
kg, c ¼ to CQ15 mg/kg, d ¼ R600 mg/kg; 1 ¼ p < 0.05, 2 ¼ p < 0.01, 3 ¼ P < 0.001;
CON ¼ Control.
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all doses was also capable of signiﬁcantly increasing the survival
time. The root extract had better suppressive activity and it
increased survival time better than the fruit extract.
Analysis of the rectal temperature revealed that 80% methanolic
fruit extract of Croton macrostachys signiﬁcantly prevented the
reduction of temperature in a dose-dependent manner (p < 0.01 for
F200 and F400; p < 0.001 for F600). The test extract prevented the
loss of weight associatedwith the increase in parasitemia at all dose
levels, compared to the negative controls. However, the increase in
body weight was not dose-dependent; the highest reduction was
caused by F400 (p < 0.001), followed (in decreasing order) by F600
(p < 0.01) and F200 (p < 0.05). There were no detectable differences
between the extracts and between the extract and standard in
preventing weight loss associated with increasing parasitemia
(Table 3).
The root extract produced similar results. It prevented the
reduction in body weight in a dose-dependent manner. All doses
also prevented a reduction in temperature. Neither the fruit nor the
root extract signiﬁcantly prevented the reduction of PCV, compared
to the negative controls.
3.4. Effect on curative test
The fruit extract in a dose-dependent manner reduced para-
sitemia by 36%, 64%, and 83% for F200, F400, and F600, respectively
(p < 0.001 in all animals), compared to the controls (Table 4). The
inhibition by CQ15 was signiﬁcantly higher than the inhibition by
F200 (p < 0.001) and F400 (p < 0.05), but it was not statistically
signiﬁcant with F600. Survival time was not altered by F200, butTable 3
Temperature, weight and PCV measurements in the 4 day suppressive test of the root an
Extract given Animal group Temperature Weigh
D0 D4 % change D0
Fruit extract CON 37.2 ± 0.19 36.5 ± 0.19 2 26.0
F200 37.5 ± 0.08 37.2 ± 0.07 0.8a2 26.1
F400 37.1 ± 0.11 37.2 ± 0.11 0.5a2 26.2
F600 37.0 ± 0.15 37.5 ± 0.15 1.3a3 26.2
CQ15 37.1 ± 0.08 37.2 ± 0.08 0.2a2 26.1
Root extract CON 37.3 ± 0.42 32.9 ± 0.21 13.3 27.9
R200 36.9 ± 0.37 36.3 ± 0.47 1.6a3 27.17
R400 37.5 ± 0.32 37.4 ± 0.23 0.3a3 27.7
R600 37.7 ± 0.49 37.4 ± 0.39 0.8a3 28.1
CQ15 37.4 ± 0.27 37.5 ± 0.26 0.26a3 26.7
Data are expressed as mean ± SEM; n ¼ 5; a ¼ compared to control, b ¼ to CQ 15 mg/kg
D4 ¼ post-treatment value on day four, CON ¼ control.was signiﬁcantly increased by F400 (p < 0.001) and F600
(p < 0.001). However, this increase could not match that obtained
with chloroquine (Table 4). The root extract produced better che-
mosuppressive activity than the fruit extract. The suppression was
dose-dependent by 43%, 70%, and 88% for R200, R400, and R600,
respectively. CQ15 produced a more signiﬁcant inhibitory effect,
compared to R200 (p < 0.001) and R400 (p < 0.05). All three doses
increased the survival time signiﬁcantly [R200 (p < 0.05), R400
(p < 0.001), and R600 (p < 0.001)]. CQ15 produced a more signiﬁ-
cant increment in survival time, compared to the controls and all
extract doses (Table 4).
Rectal temperature analysis indicated that both extracts signif-
icantly prevented the reduction of rectal temperature in compari-
son to the controls F200 (p < 0.01) < F400 (p < 0.001) < F600
(p < 0.001); R200 (p < 0.01) < R400 (p < 0.001) < R600 (p < 0.001).
A comparison of the doses did not reveal any apparent change. No
detectable changes were observed between the extract doses and
CQ15 (Table 5). Similar to the 4-day suppressive test, both extracts
failed to show any protective activity against the reduction in the
PCV (Table 5).
The extracts exhibited a preventive effect in the weight reduc-
tion of P. berghei-infected mice at all dose levels, compared to the
controls. There was no signiﬁcant difference among the extract
doses and CQ15 (Table 5).
4. Discussion
An in vivo model was employed for this study because it takes
into account a possible prodrug effect and possible involvement of
the immune system in the eradication of an infection.20 P. berghei
ANKA is used in the prediction of treatment outcomes25; hence it
was an appropriate parasite for this study. Several conventional
antimalarial agents such as chloroquine, halofantrine, meﬂoqui-
nedand more recently, artemisinin derivativesdhave been iden-
tiﬁed using the rodent malaria model.26
The 4-day suppressive test, which primarily evaluates the
antimalarial activity of candidate agents on early infections, and
Rane's test, which evaluates the curative capability of candidate
extracts on established infections, are commonly used for antima-
larial drug screening. In both methods, the determination of the
percent inhibition of parasitemia is the most reliable parameter. A
mean group parasitemia level that is  90% of that the level in
mock-treated control animals usually indicates that the test com-
pound is active in standard screening studies.27
The results from the study indicated that, in P. berghei-
infected mice, the percentage parasitemia measured in the 4-day
test was signiﬁcantly reduced in both extract-treated groups,
compared to mice in the negative control group. This indicatesd fruit extracts of Croton macrostachys.
t PCV
D4 % change D0 D4 % change
± 0.18 24.0 ± 0.43 15.5 55 ± 0.33 53 ± 0.26 3.6
± 0.12 25.3 ± 0.34 5.2 a1 53 ± 1.34 53 ± 1.48 0.0
± 0.11 25.9 ± 0.15 0.6a3 54 ± 0.50 55 ± 0.70 1.8
± 0.17 25.7 ± 0.22 2.8a2 54 ± 0.55 56 ± 0.84 3.5
± 0.09 25.5 ± 0.05 2.4 a2 53 ± 0.55 55 ± 0.42 3.8
± 0.82 26.8 ± 1.15 4.00 53.3 ± 1.46 49.7 ± 1.61 3.73
± 0.64 25.15 ± 1.16 7.43b3 51.7 ± 1.78 51.1 ± 1.1 1.14
± 1.16 26.8 ± 1.08 3.82b2 52.2 ± 1.25 52.2 ± 1.16 0.00
± 1.20 27.9 ± 1.12 0.89b1 51.7 ± 1.82 53.3 ± 1.90 3.23
± 0.51 27.3 ± 0.83 2.36a2 53.2 ± 0.48 53.9 ± 0.62 1.35
; 1 ¼ p < 0.05; 2 ¼ p < 0.01, 3 ¼ p < 0.001; D0 ¼ pre-treatment value on day zero,
Table 4
Parasitemia and survival time measurements for Rane's test of the root and fruit extracts of Croton macrostachys.
Extract administered Animal
group
Day 3 Day 4 Day 5 Day 6 Day 7 % Inhibition Survival date
Fruit extract CON 9 ± 0.15 16 ± 0.13 14 ± 0.23 31 ± 0.61 36 ± 1.10 0 6 ± 0.31
F200 12 ± 0.36 28 ± 1.20 26 ± 0.32 25 ± 0.16 23 ± 0.19 36a3,b3,c3 7 ± 0.31b3,c3
F400 11 ± 0.43 19 ± 0.95 16 ± 0.85 14 ± 0.54 13 ± 0.95 64a3,c1 12 ± 0.47a3,b3,c3
F600 10 ± 0.32 14 ± 0.56 11 ± 0.47 8 ± 0.41 6 ± 0.78 83a3 16 ± 0.42a3,c3
CQ15 11 ± 0.22 5 ± 0.09 2 ± 0.56 0 0.00 ± 0.00 100a3 30±0a3
Root extract CON 21.8 ± 0.58 26.6 ± 0.90 33.1 ± 0.81 40.7 ± 0.67 44 ± 1.34 0 5 ± 0.31
R200 20.8 ± 0.83 20.8 ± 0.66 20.2 ± 0.92 19.8 ± 0.50 25 ± 0.63 43a3,c3,d3 9 ± 0.34a1,c3,d2
R400 22.7 ± 0.63 21.2 ± 0.51 17.4 ± 0.45 15.4 ± 0.49 13 ± 0.80 70a3,c3 13 ± 0.76a3,c3,d3
R600 21.8 ± 0.79 20.9 ± 0.62 15.4 ± 1.02 11.5 ± 0.45 5 ± 0.65 88a3 18 ± 0.72a3,c3
CQ15 20.8 ± 0.85 15.6 ± 1.02 5.5 ± 0.28 1.5 ± 0.29 0.00 ± 0.00 100a3 30.0 ± 0.0a3
Data are expressed as means ± SEM; n ¼ 5; a ¼ compared to control, b ¼ to F600 mg/kg, c ¼ CQ 15 mg/kg, d ¼ R600 mg/kg; 1 ¼ p < 0.05, 2 ¼ p < 0.01, 3 ¼ P < 0.001;
CON ¼ Control.
Table 5
Rectal temperature, weight and PCV measurements in Rane's test of root and fruit extracts of Croton macrostachys.
Animal group T0 T4 % Change W0 W4 % Change PCV0 PCV4 % Change
CON 37.4 ± 0.14 36.6 ± 0.05 2.2 26.2 ± 0.21 22.1 ± 0.43 18.3 54 ± 0.31 52 ± 0.21 3.9
F200 37.3 ± 0.08 37.2 ± 0.08a2 0.2 26.3 ± 0.11 24.0 ± 0.16a1 9.6 53 ± 0.31 52 ± 0.40 1.9
F400 37.4 ± 0.09 37.4 ± 0.04a3 0.0 26.4 ± 0.11 26.1 ± 0.05a3 0.8 52.5 ± 0.43 53 ± 0.22 0.9
F600 37.3 ± 0.09 37.4 ± 0.03a3 0.2 26.5 ± 0.06 25.9 ± 0.05a2 1.9 52 ± 0.31 53 ± 0.44 1.9
CQ15 37.4 ± 0.18 37.3 ± 0.13a2 0.2 26.4 ± 0.04 25.8 ± 0.04a2 2.3 52 ± 0.42 53 ± 0.21 1.9
CON 37.8 ± 0.14 36.7 ± 0.05 2.9 26.4 ± 0.21 22.4 ± 0.43 17.8 55 ± 0.31 53 ± 0.21 3.7
R200 37.6 ± 0.08 37.0 ± 0.08a2 0.2 26.8 ± 0.11 25.0 ± 0.16a1 7.2 53 ± 0.31 51.5 ± 0.40 2.9
R400 37.5 ± 0.09 37.5 ± 0.04a3 0.0 26.4 ± 0.11 26.1 ± 0.05a3 1.1 53 ± 0.43 53 ± 0.22 0.0
R600 37.1 ± 0.09 37.8 ± 0.03a3 0.2 26.6 ± 0.06 26.4 ± 0.05a3 0.8 52.5 ± 0.31 53 ± 0.44 0.9
CQ15 37.7 ± 0.18 37.1 ± 0.13a2 0.2 26.7 ± 0.04 26.0 ± 0.04a2 2.7 54 ± 0.42 55 ± 0.21 1.8
N ¼ 5, a ¼ compared to controls, 1 ¼ p < 0.05, 2 ¼ p < 0.01, 3 ¼ p < 0.001.
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root extract with 89% and 88% parasitemia suppression and the
fruit extract with 87% and 83% parasitemia suppression for Pe-
ter's test and Rane's test, respectively, have comparable anti-
malarial activity to another species of the same genus, Croton
zambesicus, which has a maximum parasitemia suppression ac-
tivity of 80%.28 Alkaloids, phenolic compounds, and terpenoids in
these extracts could be responsible for their antimalarial activity.
The alkaloids possess antiplasmodial properties. The most
famous alkaloid is quinine. Crude extract of Euphorbiaceae
(Croton macrostachyus H.; 巴豆 ba dou) reportedly has antimi-
crobial activity.29 Furthermore, chloroform and butanol fractions
of the plant show a higher growth inhibition activity in bacteria,
whereas the aqueous fraction has no growth inhibition effect.30
Drugs with antibacterial activity such as tetracycline and its
derivatives have been implicated in malarial treatment. This
further reinforces the notion that compounds responsible for
antimalarial activity of the plant may be concentrated in
nonpolar and semipolar fractions.
Anemia, body weight loss, and body temperature reduction are
the general features of malaria-infected mice.31 Therefore, the ideal
antimalarial agents from plants are expected to prevent body
weight loss in parasite-infected mice. Despite the fact that an in-
crease in weight was not consistent with an increase in the dose,
the fruit extract of Croton macrostachys signiﬁcantly prevented
weight loss associated with an increase in the parasitemia level,
whereas the root extract prevented weight reduction in a dose-
dependent manner. This ﬁnding may indicate the presence of
appetite-suppressant secondary metabolites in the fruit extract,
rather than in the root extract, or some other difference. A decrease
in the metabolic rate in infected mice occurs before death and is
accompanied by a corresponding decrease in the internal body
temperature.32 The rectal temperature ideally decreases as the
parasite level escalates. Active compounds should prevent the rapiddropping of the rectal temperature. Both extracts did have a pro-
tective effect against temperature reduction in a dose-dependent
manner.
The PCVwasmeasured to evaluate the effectiveness of the crude
extract and fractions in preventing hemolysis due to a rising par-
asitemia level. The underlying cause of anemia includes the
followingmechanisms: the clearance and/or destruction of infected
RBC, the clearance of uninfected RBC, and erythropoietic suppres-
sion and dyserythropoiesis. Each of these mechanisms has been
implicated in human and inmousemalarial anemia.33 Both extracts
failed to prevent PCV reduction. The failure of extracts to reverse
PCV reduction could probably be associated with the presence of
saponins in the extracts, which have strong hemolytic effects.34
In the curative test, blood samples were obtained and smears
were prepared daily to evaluate the curative ability of the extract.
As indicated in the “Results” section, all doses of the extracts
reduced parasitemia after two dosings; however, the standard drug
chloroquine started its activity right after the ﬁrst dose. This delay
in activity may indicate the need for a loading dose, or the extract
may have a delayed onset of action, or the extracts may need more
frequent administrations per day.
The active compound has yet to be identiﬁed, although the
antimalarial activity of Croton macrostachyus could be attributed to
a single metabolite or a combination of its secondary metabolites
such as alkaloids, ﬂavonoids, terpenoids, and phenolic compounds.
These metabolites have been reported in the literature as having
different extents of antimalarial activity.35e37 Many species of the
genus Croton also reportedly have promising antimalarial activity
in different in vitro and in vivo studies.38
In vivo antiplasmodial activity can be classiﬁed as “moderate”,
“good”, and “very good” if an extract displays a percentage para-
sitemia suppression  50% at a dose of 500 mg/kg, 250 mg/kg, and
100 mg/kg body weight per day, respectively.39 Based on this
classiﬁcation, the root and fruit extract have good antiplasmodial
L.B. Mekonnen / Journal of Traditional and Complementary Medicine 5 (2015) 168e173 173activity, even though the root extract somewhat showed better
suppressive effect than did the fruit extract.
5. Conclusion
The results obtained from the present study revealed that both
extracts prevented a reduction in body weight and in rectal tem-
perature, which are associated with increasing parasitemia,
whereas both extracts failed to prevent a signiﬁcant reduction in
the PCV. Survival time of the extract-treated mice was also signif-
icantly prolonged. In the study, both extracts produced signiﬁcant
parasitemia suppression in both models. Further studies are
required to determine the chemical constituent responsible for the
antimalarial activity of Euphorbiaceae (Croton macrostachyus H.;巴
豆 ba dou). The plant is also an active area of research because it is
used traditionally for many disorders. The results of the study can
meanwhile be cited as evidence for claims concerning the anti-
malarial activity of the plant in Ethiopian traditional medicine.
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